Bushara, O.; Devaro, D.; Ahn, S.S.; Dourlain, J.; Farooq, M.S.; Brunetti, A.; Chen, S.; Feldser, D.; Kucharczuk, J.C.; Singhal, S.
Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma. Cancers 2025, 17, 3540.
https://doi.org/10.3390/cancers17213540
AMA Style
Bushara O, Devaro D, Ahn SS, Dourlain J, Farooq MS, Brunetti A, Chen S, Feldser D, Kucharczuk JC, Singhal S.
Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma. Cancers. 2025; 17(21):3540.
https://doi.org/10.3390/cancers17213540
Chicago/Turabian Style
Bushara, Omar, David Devaro, Shawn S. Ahn, Jordan Dourlain, Mohammad S. Farooq, Alessandro Brunetti, Simon Chen, David Feldser, John C. Kucharczuk, and Sunil Singhal.
2025. "Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma" Cancers 17, no. 21: 3540.
https://doi.org/10.3390/cancers17213540
APA Style
Bushara, O., Devaro, D., Ahn, S. S., Dourlain, J., Farooq, M. S., Brunetti, A., Chen, S., Feldser, D., Kucharczuk, J. C., & Singhal, S.
(2025). Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma. Cancers, 17(21), 3540.
https://doi.org/10.3390/cancers17213540